North America Biobanking Market is expected to reach US$ 2.27 billion by 2033 | PHC Corporation, Merck KGaA, Avantor, Inc., Cryoport Systems

North America Biobanking Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

North America biobanking market reached US$ 1.09 billion in 2024 and is expected to reach US$ 2.27 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/north-america-biobanking-market?sg

Market opportunities and Growth Drivers

The North American biobanking market is expanding rapidly, fueled by breakthroughs in biotechnology and genomics that underpin personalized medicine and targeted therapies. As researchers seek biomarkers and genetic variants in conditions such as cancer, cardiovascular disease, and neurological disorders, demand for high‐quality biological samples has surged.

Biobanks supply the well‐preserved tissue, blood, and DNA specimens critical for advanced analyses whether in genomics, transcriptomics, or epigenomics. Next‐generation sequencing platforms (for example, Illumina's NGS systems) generate vast data sets and rely on robust sample storage and data‐management workflows to maintain integrity and traceability of those samples.

In the United States, large‐scale efforts like the NIH's All of Us Research Program aiming to gather genomic and health information from more than one million participants have created an urgent need for scalable biobanking infrastructure. Meanwhile, innovations in CRISPR and other gene‐editing tools further intensify requirements for precise sample handling and long‐term preservation. Together, these trends position biobanks as indispensable partners in North America's quest to translate genomic insights into next‐generation diagnostics and therapies.

List of the Key Players in the North America Biobanking Market: Thermo Fisher Scientific Inc., QIAGEN N.V., PHC Corporation, Merck KGaA, Avantor, Inc., Cryoport Systems, LLC., Tecan Group Ltd., Azenta US Inc., Greiner Bio-One North America Inc., Hamilton Company.

Assessing the Effects of U.S. Tariffs on the North America Biobanking Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global North America Biobanking Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/north-america-biobanking-market?sg

Segment Covered in the North America Biobanking Market:

By Specimen Type (Blood, Tissues, Cell Lines, Nucleic Acids, Others)

By Product & Services (Equipments, Consumables, Services, Software

By Storage Type (Manual Storage, Automated Storage)

By Application (Therapeutic Research, Life Science Research, Regenerative Medicine, Clinical Diagnostics, Personalized Medicine, Others)

By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Others)

Regional Analysis for North America Biobanking Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Browse More Reports: https://www.datamintelligence.com/research-report/north-america-biobanking-market?sg

Most Frequently Asked Questions in the North America Biobanking Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the North America Biobanking market?

➠ Who are the top manufacturers in the global North America Biobanking industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the North America Biobanking market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the North America Biobanking market?

➠ What are the primary sales, marketing, and distribution strategies used across the global North America Biobanking industry landscape?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.